Cardiac amyloidosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Cardiac amyloidosis}} {{CMG}}{{AE}}{{Sab}} ==Overview== ==Other Diagnostic Studies== ==References== {{Reflist|2}}") |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Reduced [[heart rate variability]] due to [[autonomic dysfunction]] can be observed on [[Holter monitor|Holter monitoring]]. This lack of [[Heart rate variability|variability in the heart rate]] has been shown to be a more consistent predictive parameter of short-term [[mortality]] in [[Patient|patients]] with [[AL type amyloidosis]] with [[Heart|cardiac]] involvement as compared to those with [[AA type amyloidosis]]. | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
===Holter Monitoring=== | |||
* Reduced [[heart rate variability]] due to [[autonomic dysfunction]] can be observed on [[Holter monitor|Holter monitoring]]. | |||
* Reduced [[heart rate variability]] is a predictor of 1-year [[mortality]] in cardiac amyloidosis [[Patient|patients]].<ref name="pmid11785998">{{cite journal |author=Reyners AK, Hazenberg BP, Reitsma WD, Smit AJ |title=Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis |journal=[[European Heart Journal]] |volume=23 |issue=2 |pages=157–61 |year=2002 |month=January |pmid=11785998 |doi=10.1053/euhj.2001.2972 |url=}}</ref> | |||
* This lack of [[Heart rate variability|variability in the heart rate]] has been shown to be a more consistent predictive parameter of short-term [[mortality]] in [[Patient|patients]] with [[AL type amyloidosis]] with [[Heart|cardiac]] involvement as compared to those with [[AA type amyloidosis]]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 21:53, 30 October 2019
|
Cardiac amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac amyloidosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Cardiac amyloidosis other diagnostic studies |
|
Risk calculators and risk factors for Cardiac amyloidosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Reduced heart rate variability due to autonomic dysfunction can be observed on Holter monitoring. This lack of variability in the heart rate has been shown to be a more consistent predictive parameter of short-term mortality in patients with AL type amyloidosis with cardiac involvement as compared to those with AA type amyloidosis.
Other Diagnostic Studies
Holter Monitoring
- Reduced heart rate variability due to autonomic dysfunction can be observed on Holter monitoring.
- Reduced heart rate variability is a predictor of 1-year mortality in cardiac amyloidosis patients.[1]
- This lack of variability in the heart rate has been shown to be a more consistent predictive parameter of short-term mortality in patients with AL type amyloidosis with cardiac involvement as compared to those with AA type amyloidosis.
References
- ↑ Reyners AK, Hazenberg BP, Reitsma WD, Smit AJ (2002). "Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis". European Heart Journal. 23 (2): 157–61. doi:10.1053/euhj.2001.2972. PMID 11785998. Unknown parameter
|month=ignored (help)